CCA
ABBV icon

Childress Capital Advisors’s AbbVie ABBV Stock Holding History

Childress Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23M Sell
10,251
-477
-4% -$106K 0.4% 41
2025
Q4 		$2.45M Buy
10,728
+1,040
+11% +$237K 0.39% 45
2025
Q3 		$2.24M Buy
9,688
+1,378
+17% +$281K 0.41% 44
2025
Q2 		$1.54M Buy
8,310
+1,667
+25% +$310K 0.39% 43
2025
Q1 		$1.39M Buy
6,643
+89
+1% +$17.3K 0.4% 46
2024
Q4 		$1.16M Sell
6,554
-69
-1% -$12.7K 0.32% 52
2024
Q3 		$1.31M Buy
6,623
+121
+2% +$22.6K 0.35% 49
2024
Q2 		$1.12M Buy
6,502
+138
+2% +$22.9K 0.31% 54
2024
Q1 		$1.16M Sell
6,364
-466
-7% -$80.3K 0.34% 52
2023
Q4 		$1.06M Buy
6,830
+251
+4% +$36.6K 0.32% 52
2023
Q3 		$983K Buy
+6,579
New +$966K 0.32% 55
2023
Q2 		– Sell
-2,123
Closed -$338K – 75
2023
Q1 		$338K Sell
2,123
-5,024
-70% -$768K 0.15% 61
2022
Q4 		$1.16M Buy
7,147
+531
+8% +$81.4K 0.38% 48
2022
Q3 		$899K Sell
6,616
-210
-3% -$30.1K 0.35% 53
2022
Q2 		$1.04M Buy
6,826
+293
+4% +$44.8K 0.41% 49
2022
Q1 		$1.06M Buy
6,533
+125
+2% +$18.2K 0.37% 50
2021
Q4 		$868K Sell
6,408
-1,655
-21% -$195K 0.36% 54
2021
Q3 		$869K Buy
8,063
+3,913
+94% +$447K 0.35% 58
2021
Q2 		$467K Sell
4,150
-3,711
-47% -$418K 0.21% 82
2021
Q1 		$850K Buy
7,861
+2,525
+47% +$270K 0.39% 49
2020
Q4 		$574K Buy
+5,336
New +$513K 0.34% 37

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Childress Capital Advisors's ABBV Position: Q1 2026 in Review

Childress Capital Advisors reduced its AbbVie (ABBV) stake by 4.4% in Q1 2026, selling an estimated $106K and leaving 10,251 shares worth $2.23M. The position accounts for 0.4% of the portfolio, ranked #41.

Childress Capital Advisors first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.45M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Childress Capital Advisors held 10,251 shares of AbbVie worth $2.23M as of Q1 2026.
  • Childress Capital Advisors sold 477 AbbVie shares in Q1 2026, an estimated $106K.
  • AbbVie made up 0.4% of Childress Capital Advisors's portfolio in Q1 2026, its #41 holding.
  • Childress Capital Advisors first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • Childress Capital Advisors's AbbVie position peaked at $2.45M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.